BNET Industries
Last Fiscal Year Sales:$30.9M
- Public
- US
Dow Jones Description
Endocrine and metabolic diseases pose unique challenges to the scientific and clinical communities. Patients afflicted with these conditions often face great compromises in their quality of life, and they look to the innovators in biomedical science to offer new, more effective treatments. At Tercica, we take our responsibility to these patients very seriously, and we recognize that important advances are most likely to result when we share knowledge and resources. By fostering strategic partnerships with leading biopharmaceutical companies like Genentech and Ipsen SA, Tercica has already succeeded in bringing two novel products to market. Today, we continue to pursue partnerships with the scientific and clinical communities to develop promising new therapies that help many patients to live fuller, healthier lives.
Number of Employees 126
Contact Information
2000 Sierra Point Pkwy Ste 400
Brisbane, California 94005-1849
(650) 624-4900
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
News & Analysis
Filter by
investment and tercica inc. - All News and Analysis
Tercica Reports Second Quarter 2008 Financial Results
- 2008-07-31
BRISBANE, Calif. -- Tercica, Inc. (Nasdaq: TRCA) today announced financial results for the quarter ended June 30, 2008. Net product sales totaled $6.2 million, compared to $2.0 million in the second quarter of 2007. Net product sales for Increlex([R]) and Somatuline([R]) Depot in the second quarter of 2008 were $4.6...
Ipsen to Acquire Tercica
- 2008-06-05
-- $9.00 per Share to Be Paid in Cash -- BRISBANE, Calif. -- Tercica, Inc. (Nasdaq: TRCA) today announced that Tercica and Ipsen, S.A. (Euronext: IPN) have entered into a definitive merger agreement by which an affiliate of Ipsen would acquire all of the shares of Tercica common stock...
More Breaking Headlines from Solar EnerTech Corp. (OTCBB: SOEN).
- 2007-03-09
M2 PRESSWIRE-9 March 2007-AnalystStockReport.com: More Breaking Headlines from Solar EnerTech Corp. (OTCBB: SOEN)C1994-2007 M2 COMMUNICATIONS LTD RDATE:09032007 Stocks To Watch: Solar EnerTech Corp. (OTCBB: SOEN), SLEEP HOLDINGS, INC. (PinkSheets: SLHJ), Tercica Inc. (Nasdaq: TRCA), Terrace Ventures, Inc., (OTCBB: TVEN), International...
- 1
Industry Transcripts by Seeking Alpha
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
Glass Door
Pharma Industry Companies
| Company | Employer Rating |
| Johnson & Johnson |  |
| Merck | |
| Pfizer | |
| Novartis |  |
| Abbott Labs | |
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- More Tysabri Problems; Time for a Biogen-Idec Credibility Check 3 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes
